Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Paget's Disease, Mammary × Docosahexaenoic Acids × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 11 Breast Carcinoma In Situ 2 Weight Loss 1 Paget's Disease, Mammary 1 Neoplasms 1 Fatigue 1 Cognitive Dysfunction 1 Carcinoma, Intraductal, Noninfiltrating 1 Arthralgia 1

Interventions

Tamoxifen 1 Medroxyprogesterone 1 Docosahexaenoic Acids 1 Chemotherapy, Adjuvant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01849250 2021-12-28

Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors

National Cancer Institute (NCI)

Phase 2 Completed

65 enrolled 11 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Paget's Disease, Mammary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡